Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Dietz-Fricke C, Degasperi E, Jachs M, Maasoumy B, Reiter FP, Geier A, Grottenthaler JM, Berg CP, Sprinzl K, Zeuzem S, Gödiker J, Schlevogt B, Herta T, Wiegand J, Soffredini R, Wedemeyer H, Deterding K, Reiberger T, Lampertico P. Dietz-Fricke C, et al. Among authors: deterding k. Hepatology. 2024 Sep 1;80(3):664-673. doi: 10.1097/HEP.0000000000000847. Epub 2024 Mar 13. Hepatology. 2024. PMID: 38478755 Free PMC article.
[Acute viral hepatitis].
Deterding K. Deterding K. Dtsch Med Wochenschr. 2024 Aug;149(16):941-947. doi: 10.1055/a-2057-1761. Epub 2024 Aug 2. Dtsch Med Wochenschr. 2024. PMID: 39094598 Review. German.
Steroid treatment for severe acute cryptogenic hepatitis.
Potthoff A, Deterding K, Trautwein C, Flemming P, Strassburg CP, Manns MP, Wedemeyer H, Bahr MJ. Potthoff A, et al. Among authors: deterding k. Z Gastroenterol. 2007 Jan;45(1):15-9. doi: 10.1055/s-2006-927280. Z Gastroenterol. 2007. PMID: 17236116
Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
Potthoff A, Deterding K, Trautwein C, Rifai K, Manns MP, Wedemeyer H. Potthoff A, et al. Among authors: deterding k. Eur J Gastroenterol Hepatol. 2007 Oct;19(10):906-9. doi: 10.1097/MEG.0b013e3282094160. Eur J Gastroenterol Hepatol. 2007. PMID: 17873617
Clearance of chronic HCV infection during acute delta hepatitis.
Deterding K, Pothakamuri SV, Schlaphoff V, Hadem J, Metzler F, Bahr MJ, Manns MP, Cornberg M, Wedemeyer H. Deterding K, et al. Infection. 2009 Apr;37(2):159-62. doi: 10.1007/s15010-007-7204-7. Epub 2007 Dec 14. Infection. 2009. PMID: 18084714
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J, Spengler U, Gruengreiff K, Kaeser T, Schuchmann M, Bergk A, Forestier N, Deterding K, Manns MP, Trautwein C; Hep-Net B/C Co-infection Study Group. Potthoff A, et al. Among authors: deterding k. J Hepatol. 2008 Nov;49(5):688-94. doi: 10.1016/j.jhep.2008.03.028. Epub 2008 Apr 29. J Hepatol. 2008. PMID: 18490077 Clinical Trial.
113 results